Deutsche Bank
OLMA icon

Deutsche Bank’s Olema Pharmaceuticals OLMA Stock Holding History

Deutsche Bank’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Sell
95,834
-65,562
-41% -$878K ﹤0.01% 2237
2026
Q1 		$2.41M Buy
161,396
+98,329
+156% +$2.19M ﹤0.01% 1683
2025
Q4 		$1.58M Buy
63,067
+1,975
+3% +$35.1K ﹤0.01% 1932
2025
Q3 		$598K Buy
61,092
+6,982
+13% +$41.9K ﹤0.01% 2457
2025
Q2 		$231K Sell
54,110
-219
-0.4% -$976 ﹤0.01% 2879
2025
Q1 		$204K Buy
54,329
+14,998
+38% +$75.4K ﹤0.01% 2938
2024
Q4 		$229K Buy
39,331
+12,199
+45% +$122K ﹤0.01% 3037
2024
Q3 		$324K Sell
27,132
-226,742
-89% -$2.9M ﹤0.01% 2688
2024
Q2 		$2.75M Buy
253,874
+4,844
+2% +$52.5K ﹤0.01% 1487
2024
Q1 		$2.82M Buy
249,030
+369
+0.1% +$4.76K ﹤0.01% 1501
2023
Q4 		$3.49M Buy
248,661
+234,143
+1,613% +$3.15M ﹤0.01% 1404
2023
Q3 		$179K Sell
14,518
-234,177
-94% -$2.39M ﹤0.01% 2858
2023
Q2 		$2.25M Sell
248,695
-6,023
-2% -$36.4K ﹤0.01% 1566
2023
Q1 		$884K Sell
254,718
-201,948
-44% -$824K ﹤0.01% 2170
2022
Q4 		$1.12M Hold
456,666
– – ﹤0.01% 1986
2022
Q3 		$1.26M Hold
456,666
– – ﹤0.01% 1837
2022
Q2 		$1.86M Buy
456,666
+400,229
+709% +$1.27M ﹤0.01% 1806
2022
Q1 		$240K Sell
56,437
-50,728
-47% -$280K ﹤0.01% 3159
2021
Q4 		$1M Buy
107,165
+980
+0.9% +$20.3K ﹤0.01% 2435
2021
Q3 		$2.93M Buy
106,185
+7,094
+7% +$191K ﹤0.01% 1832
2021
Q2 		$2.77M Buy
99,091
+85,615
+635% +$2.44M ﹤0.01% 1934
2021
Q1 		$447K Buy
+13,476
New +$577K ﹤0.01% 3173

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Deutsche Bank's OLMA Position: Q2 2026 in Review

Deutsche Bank reduced its Olema Pharmaceuticals (OLMA) stake by 41% in Q2 2026, selling an estimated $878K and leaving 95,834 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2237.

Deutsche Bank first reported a position in OLMA in Q1 2021 and has held it in 22 quarters since. The position peaked at $3.49M in Q4 2023. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Deutsche Bank held 95,834 shares of Olema Pharmaceuticals worth $1.2M as of Q2 2026.
  • Deutsche Bank sold 65,562 Olema Pharmaceuticals shares in Q2 2026, an estimated $878K.
  • Olema Pharmaceuticals made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2237 holding.
  • Deutsche Bank first reported a position in Olema Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • Deutsche Bank's Olema Pharmaceuticals position peaked at $3.49M in Q4 2023.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.